1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Pyrogen Testing Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Pyrogen Testing Market, by Test Type
8.1.1. Limulus Amebocyte Lysate testing
8.1.1.1. Market Revenue and Forecast
8.1.2. Monocyte Activation Test
8.1.2.1. Market Revenue and Forecast
8.1.3. Rabbit Pyrogen Test
8.1.3.1. Market Revenue and Forecast
9.1. Pyrogen Testing Market, by Offering Type
9.1.1. Reagents and Kits
9.1.1.1. Market Revenue and Forecast
9.1.2. Instruments and Readers
9.1.2.1. Market Revenue and Forecast
9.1.3. Consumables
9.1.3.1. Market Revenue and Forecast
9.1.4. Services
9.1.4.1. Market Revenue and Forecast
10.1. Pyrogen Testing Market, by Application
10.1.1. Pharmaceutical Products Testing
10.1.1.1. Market Revenue and Forecast
10.1.2. Biologics and Biotechnology Products Testing
10.1.2.1. Market Revenue and Forecast
10.1.3. Medical Devices Testing
10.1.3.1. Market Revenue and Forecast
10.1.4. Cell and Gene Therapy Products Testing
10.1.4.1. Market Revenue and Forecast
10.1.5. Vaccine Testing
10.1.5.1. Market Revenue and Forecast
11.1. Pyrogen Testing Market, by End User
11.1.1. Pharmaceutical Companies
11.1.1.1. Market Revenue and Forecast
11.1.2. Biotechnology Companies
11.1.2.1. Market Revenue and Forecast
11.1.3. Contract Research Organizations
11.1.3.1. Market Revenue and Forecast
11.1.4. Academic and Research Institutes
11.1.4.1. Market Revenue and Forecast
11.1.5. Medical Device Manufacturers
11.1.5.1. Market Revenue and Forecast
12.1. Pyrogen Testing Market, by Technology
12.1.1. Gel Clot LAL Method
12.1.1.1. Market Revenue and Forecast
12.1.2. Turbidimetric LAL Method
12.1.2.1. Market Revenue and Forecast
12.1.3. Chromogenic LAL Method
12.1.3.1. Market Revenue and Forecast
12.1.4. Recombinant Factor C Assay
12.1.4.1. Market Revenue and Forecast
13.1. Pyrogen Testing Market, by Sample Type
13.1.1. Injectable Drugs
13.1.1.1. Market Revenue and Forecast
13.1.2. Implantable Medical Devices
13.1.2.1. Market Revenue and Forecast
13.1.3. Parenteral Nutrition Products
13.1.3.1. Market Revenue and Forecast
13.1.4. Dialysis Products
13.1.4.1. Market Revenue and Forecast
13.1.5. Vaccines
13.1.5.1. Market Revenue and Forecast
14.1. North America
14.1.1. Market Revenue and Forecast, by Test Type
14.1.2. Market Revenue and Forecast, by Offering Type
14.1.3. Market Revenue and Forecast, by Application
14.1.4. Market Revenue and Forecast, by End User
14.1.5. Market Revenue and Forecast, by Technology
14.1.6. Market Revenue and Forecast, by Sample Type
14.1.7. U.S.
14.1.7.1. Market Revenue and Forecast, by Test Type
14.1.7.2. Market Revenue and Forecast, by Offering Type
14.1.7.3. Market Revenue and Forecast, by Application
14.1.7.4. Market Revenue and Forecast, by End User
14.1.8. Market Revenue and Forecast, by Technology
14.1.8.1. Market Revenue and Forecast, by Sample Type
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Forecast, by Test Type
14.1.9.2. Market Revenue and Forecast, by Offering Type
14.1.9.3. Market Revenue and Forecast, by Application
14.1.9.4. Market Revenue and Forecast, by End User
14.1.10. Market Revenue and Forecast, by Technology
14.1.11. Market Revenue and Forecast, by Sample Type
14.2. Europe
14.2.1. Market Revenue and Forecast, by Test Type
14.2.2. Market Revenue and Forecast, by Offering Type
14.2.3. Market Revenue and Forecast, by Application
14.2.4. Market Revenue and Forecast, by End User
14.2.5. Market Revenue and Forecast, by Technology
14.2.6. Market Revenue and Forecast, by Sample Type
14.2.8. UK
14.2.8.1. Market Revenue and Forecast, by Test Type
14.2.8.2. Market Revenue and Forecast, by Offering Type
14.2.8.3. Market Revenue and Forecast, by Application
14.2.9. Market Revenue and Forecast, by End User
14.2.10. Market Revenue and Forecast, by Technology
14.2.10.1. Market Revenue and Forecast, by Sample Type
14.2.11. Germany
14.2.11.1. Market Revenue and Forecast, by Test Type
14.2.11.2. Market Revenue and Forecast, by Offering Type
14.2.11.3. Market Revenue and Forecast, by Application
14.2.12. Market Revenue and Forecast, by End User
14.2.13. Market Revenue and Forecast, by Technology
14.2.14. Market Revenue and Forecast, by Sample Type
14.2.15. France
14.2.15.1. Market Revenue and Forecast, by Test Type
14.2.15.2. Market Revenue and Forecast, by Offering Type
14.2.15.3. Market Revenue and Forecast, by Application
14.2.15.4. Market Revenue and Forecast, by End User
14.2.16. Market Revenue and Forecast, by Technology
14.2.16.1. Market Revenue and Forecast, by Sample Type
14.2.17. Rest of Europe
14.2.17.1. Market Revenue and Forecast, by Test Type
14.2.17.2. Market Revenue and Forecast, by Offering Type
14.2.17.3. Market Revenue and Forecast, by Application
14.2.17.4. Market Revenue and Forecast, by End User
14.2.18. Market Revenue and Forecast, by Technology
14.2.18.1. Market Revenue and Forecast, by Sample Type
14.3. APAC
14.3.1. Market Revenue and Forecast, by Test Type
14.3.2. Market Revenue and Forecast, by Offering Type
14.3.3. Market Revenue and Forecast, by Application
14.3.4. Market Revenue and Forecast, by End User
14.3.5. Market Revenue and Forecast, by Technology
14.3.6. Market Revenue and Forecast, by Sample Type
14.3.7. India
14.3.7.1. Market Revenue and Forecast, by Test Type
14.3.7.2. Market Revenue and Forecast, by Offering Type
14.3.7.3. Market Revenue and Forecast, by Application
14.3.7.4. Market Revenue and Forecast, by End User
14.3.8. Market Revenue and Forecast, by Technology
14.3.9. Market Revenue and Forecast, by Sample Type
14.3.10. China
14.3.10.1. Market Revenue and Forecast, by Test Type
14.3.10.2. Market Revenue and Forecast, by Offering Type
14.3.10.3. Market Revenue and Forecast, by Application
14.3.10.4. Market Revenue and Forecast, by End User
14.3.11. Market Revenue and Forecast, by Technology
14.3.11.1. Market Revenue and Forecast, by Sample Type
14.3.12. Japan
14.3.12.1. Market Revenue and Forecast, by Test Type
14.3.12.2. Market Revenue and Forecast, by Offering Type
14.3.12.3. Market Revenue and Forecast, by Application
14.3.12.4. Market Revenue and Forecast, by End User
14.3.12.5. Market Revenue and Forecast, by Technology
14.3.12.6. Market Revenue and Forecast, by Sample Type
14.3.13. Rest of APAC
14.3.13.1. Market Revenue and Forecast, by Test Type
14.3.13.2. Market Revenue and Forecast, by Offering Type
14.3.13.3. Market Revenue and Forecast, by Application
14.3.13.4. Market Revenue and Forecast, by End User
14.3.13.5. Market Revenue and Forecast, by Technology
14.3.13.6. Market Revenue and Forecast, by Sample Type
14.4. MEA
14.4.1. Market Revenue and Forecast, by Test Type
14.4.2. Market Revenue and Forecast, by Offering Type
14.4.3. Market Revenue and Forecast, by Application
14.4.4. Market Revenue and Forecast, by End User
14.4.5. Market Revenue and Forecast, by Technology
14.4.6. Market Revenue and Forecast, by Sample Type
14.4.7. GCC
14.4.7.1. Market Revenue and Forecast, by Test Type
14.4.7.2. Market Revenue and Forecast, by Offering Type
14.4.7.3. Market Revenue and Forecast, by Application
14.4.7.4. Market Revenue and Forecast, by End User
14.4.8. Market Revenue and Forecast, by Technology
14.4.9. Market Revenue and Forecast, by Sample Type
14.4.10. North Africa
14.4.10.1. Market Revenue and Forecast, by Test Type
14.4.10.2. Market Revenue and Forecast, by Offering Type
14.4.10.3. Market Revenue and Forecast, by Application
14.4.10.4. Market Revenue and Forecast, by End User
14.4.11. Market Revenue and Forecast, by Technology
14.4.12. Market Revenue and Forecast, by Sample Type
14.4.13. South Africa
14.4.13.1. Market Revenue and Forecast, by Test Type
14.4.13.2. Market Revenue and Forecast, by Offering Type
14.4.13.3. Market Revenue and Forecast, by Application
14.4.13.4. Market Revenue and Forecast, by End User
14.4.13.5. Market Revenue and Forecast, by Technology
14.4.13.6. Market Revenue and Forecast, by Sample Type
14.4.14. Rest of MEA
14.4.14.1. Market Revenue and Forecast, by Test Type
14.4.14.2. Market Revenue and Forecast, by Offering Type
14.4.14.3. Market Revenue and Forecast, by Application
14.4.14.4. Market Revenue and Forecast, by End User
14.4.14.5. Market Revenue and Forecast, by Technology
14.4.14.6. Market Revenue and Forecast, by Sample Type
14.5. Latin America
14.5.1. Market Revenue and Forecast, by Test Type
14.5.2. Market Revenue and Forecast, by Offering Type
14.5.3. Market Revenue and Forecast, by Application
14.5.4. Market Revenue and Forecast, by End User
14.5.5. Market Revenue and Forecast, by Technology
14.5.6. Market Revenue and Forecast, by Sample Type
14.5.7. Brazil
14.5.7.1. Market Revenue and Forecast, by Test Type
14.5.7.2. Market Revenue and Forecast, by Offering Type
14.5.7.3. Market Revenue and Forecast, by Application
14.5.7.4. Market Revenue and Forecast, by End User
14.5.8. Market Revenue and Forecast, by Technology
14.5.8.1. Market Revenue and Forecast, by Sample Type
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Forecast, by Test Type
14.5.9.2. Market Revenue and Forecast, by Offering Type
14.5.9.3. Market Revenue and Forecast, by Application
14.5.9.4. Market Revenue and Forecast, by End User
14.5.9.5. Market Revenue and Forecast, by Technology
14.5.9.6. Market Revenue and Forecast, by Sample Type
15.1. Charles River Laboratories
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Lonza Group
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. Thermo Fisher Scientific
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Merck KGaA
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. BioMérieux
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. Associates of Cape Cod
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Wako Chemicals USA
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. GenScript
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. Creative Bioarray
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. Hyglos GmbH
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
17.1. About Us
17.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client